Literature DB >> 12019066

Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci.

Stephan Harbarth1, Sara Cosgrove, Yehuda Carmeli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12019066      PMCID： PMC127216          DOI： 10.1128/AAC.46.6.1619-1628.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  108 in total

1.  Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients.

Authors:  C J Donskey; T K Chowdhry; M T Hecker; C K Hoyen; J A Hanrahan; A M Hujer; R A Hutton-Thomas; C C Whalen; R A Bonomo; L B Rice
Journal:  N Engl J Med       Date:  2000-12-28       Impact factor: 91.245

2.  Divergent biases in ecologic and individual-level studies.

Authors:  S Greenland
Journal:  Stat Med       Date:  1992-06-30       Impact factor: 2.373

3.  Effect of oral Bacillus coagulans administration on the density of vancomycin-resistant enterococci in the stool of colonized mice.

Authors:  C J Donskey; C K Hoyen; S M Das; S Farmer; M Dery; R A Bonomo
Journal:  Lett Appl Microbiol       Date:  2001-07       Impact factor: 2.858

4.  A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit.

Authors:  S Slaughter; M K Hayden; C Nathan; T C Hu; T Rice; J Van Voorhis; M Matushek; C Franklin; R A Weinstein
Journal:  Ann Intern Med       Date:  1996-09-15       Impact factor: 25.391

5.  Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection.

Authors:  K J Henning; H Delencastre; J Eagan; N Boone; A Brown; M Chung; N Wollner; D Armstrong
Journal:  Pediatr Infect Dis J       Date:  1996-10       Impact factor: 2.129

6.  Control of endemic glycopeptide-resistant enterococci.

Authors:  L M Dembry; K Uzokwe; M J Zervos
Journal:  Infect Control Hosp Epidemiol       Date:  1996-05       Impact factor: 3.254

7.  Enterococcus faecium bacteremia: does vancomycin resistance make a difference?

Authors:  V Stosor; L R Peterson; M Postelnick; G A Noskin
Journal:  Arch Intern Med       Date:  1998-03-09

8.  Observations on the risk of resistance with the extended use of vancomycin.

Authors:  A T McManus; C W Goodwin; B A Pruitt
Journal:  Arch Surg       Date:  1998-11

9.  Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection.

Authors:  M B Edmond; J F Ober; D L Weinbaum; M A Pfaller; T Hwang; M D Sanford; R P Wenzel
Journal:  Clin Infect Dis       Date:  1995-05       Impact factor: 9.079

Review 10.  Emergence of vancomycin-resistant enterococci.

Authors:  L B Rice
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883
View more
  49 in total

1.  Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage.

Authors:  James A McKinnell; Danielle F Kunz; Eric Chamot; Mukesh Patel; Rhett M Shirley; Stephen A Moser; John W Baddley; Peter G Pappas; Loren G Miller
Journal:  Infect Control Hosp Epidemiol       Date:  2012-05-14       Impact factor: 3.254

Review 2.  Antimicrobial Lessons From a Large Observational Cohort on Intra-abdominal Infections in Intensive Care Units.

Authors:  Dirk Vogelaers; Stijn Blot; Andries Van den Berge; Philippe Montravers
Journal:  Drugs       Date:  2021-05-26       Impact factor: 9.546

3.  Evaluation of Spectra VRE, a new chromogenic agar medium designed to screen for vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.

Authors:  Jess F Peterson; Christopher D Doern; George Kallstrom; Katherine M Riebe; Tara Sander; William Michael Dunne; Nathan A Ledeboer
Journal:  J Clin Microbiol       Date:  2010-10-13       Impact factor: 5.948

4.  Vancomycin-resistant enterococci colonization in patients with hematological malignancies: screening and its cost-effectiveness.

Authors:  Habip Gedik; Funda Şimşek; Arzu Kantürk; Taner Yıldırmak; Deniz Arıca; Demet Aydın; Osman Yokuş; Naciye Demirel
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

Review 5.  Antimicrobial stewardship programs in health care systems.

Authors:  Conan MacDougall; Ron E Polk
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

Review 6.  Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals.

Authors:  I Klare; C Konstabel; S Mueller-Bertling; G Werner; B Strommenger; C Kettlitz; S Borgmann; B Schulte; D Jonas; A Serr; A M Fahr; U Eigner; W Witte
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

Review 7.  Emerging antibiotic resistance in bacteria with special reference to India.

Authors:  D Raghunath
Journal:  J Biosci       Date:  2008-11       Impact factor: 1.826

8.  Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease.

Authors:  Wafa N Al-Nassir; Ajay K Sethi; Yuejin Li; Michael J Pultz; Michelle M Riggs; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2008-04-28       Impact factor: 5.191

Review 9.  Critical issues in the clinical management of complicated intra-abdominal infections.

Authors:  Stijn Blot; Jan J De Waele
Journal:  Drugs       Date:  2005       Impact factor: 9.546

10.  Multiple antibiotic resistance gene transfer from animal to human enterococci in the digestive tract of gnotobiotic mice.

Authors:  C Moubareck; N Bourgeois; P Courvalin; F Doucet-Populaire
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.